“Whether the district court erred in holding that any reasonable juror was required to find that Sanofi-Regeneron established non-enablement by clear-and- convincing evidence.”
“We agree with the district court’s finding that the specification here did not enable preparation of the full scope of these double-function claims without undue experimentation. . . . For the reasons above, we affirm the district court’s determination that the asserted claims are invalid for lack of enablement.”
